Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review

(2018) Roland Diel et al.   BMC INFECTIOUS DISEASES

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages

(2018) Jimin Zhang et al.   Frontiers in Microbiology

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study

(2018) David E Griffith et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)

(2018) KEVIN WINTHROP et al.   CHEST

Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population

(2018) Theodore K. Marras et al.   RESPIRATORY MEDICINE

Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats

(2016) Vladimir Malinin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular basis of mycobacterial survival in macrophages

(2016) Jane Atesoh Awuh et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung Disease

(2016) Hye Yun Park et al.   CHEST

Inhaled antimicrobial therapy – Barriers to effective treatment

(2015) Jeffry Weers   ADVANCED DRUG DELIVERY REVIEWS

Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria

(2015) D. Rebecca Prevots et al.   CLINICS IN CHEST MEDICINE

Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease

(2014) Richard J. Wallace et al.   CHEST

Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection

(2014) Sasha J. Rose et al.   PLoS One

In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates

(2013) B. A. Brown-Elliott et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria

(2012) B. A. Brown-Elliott et al.   CLINICAL MICROBIOLOGY REVIEWS

Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease

(2011) Mauli Mehta et al.   RESPIRATORY MEDICINE

Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems

(2010) D. Rebecca Prevots et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers

(2009) Jeffry Weers et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections

(2008) P. Meers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY